Innovation and Technology Tariff
NHS England will fast-track the introduction of seven types of medical technology products during 2017/18 through the Innovation and Technology Tariff (ITT).
The Tariff removes the need for multiple local price negotiations and allows automatic reimbursement from NHS England based on four different models:
- Care providers can order four of the innovations directly from the supplier at no cost (NHS England will then reimburse the supplier directly)
- NHS England will reimburse money for one of the innovations based on the number of times it is used
- One of the innovations is an alternative to existing surgery and is already funded as part of NHS England tariff calculations
- One innovation category will be paid for by NHS England upfront and distributed regionally via Academic Health Science Networks.
The four innovations that Care providers can order directly from the supplier at no cost are:
- Arterial connecting systems to reduce bacterial contamination and the accidental administration of medication. For example, Non-Injectable Arterial Connector Implementation. Read the implementation toolkit
- Pneumonia prevention systems which are designed to stop ventilator-associated pneumonia. For example, PneuX. Read the implementation toolkit
- Web-based applications for the self-management of chronic obstructive pulmonary disease (COPD). For example, myCOPD by MyMHealth. Read the implementation toolkit
- Frozen Faecal microbiota transplantation (FMT) for recurrent Clostridium difficile infection rates.
The innovation to be reimbursed based on the number of uses is:
- Guided mediolateral episiotomy to minimise the risk of obstetric anal sphincter injury. For example, EpiScissors-60. Read the implementation toolkit
The innovation funded through existing tariff calculations is:
- Management of Benign prostatic hyperplasia as a day case (purchased through National Tariff). For example, Urolift.
The innovation category paid for by NHS England and distributed via your local AHSN is:
- Identification of atrial fibrillation through the use of mobile ECG technology - For example, AliveCorKardia. Read the implementation toolkit
The tariff went live on 01 April 2017, and NHS England and AHSNs are encouraging the widespread purchase, reimbursement and use of these technologies. For further information on the Tariff please go to the link below and/or email Stuart Monk, Interim Director of Innovation on firstname.lastname@example.org
For upcoming ITT events click here
- How we help NHS organisations
- How we help industry
- How we help charities & social enterprises
- Our innovation priorities
- Innovation Pathway